Triazole-based inhibitors of geranylgeranyltransferase II

Xiang Zhou, Sara V. Hartman, Ella J. Born, Jacqueline P. Smits, Sarah A. Holstein, David F. Wiemer

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


A small set of triazole bisphosphonates has been prepared and tested for the ability to inhibit geranylgeranyltransferase II (GGTase II). The compounds were prepared through use of click chemistry to assemble a central triazole that links a polar head group to a hydrophobic tail. The resulting compounds were tested for their ability to inhibit GGTase II in an in vitro enzyme assay and also were tested for cytotoxic activity in an MTT assay with the human myeloma RPMI-8226 cell line. The most potent enzyme inhibitor was the triazole with a geranylgeranyl tail, which suggests that inhibitors that can access the enzyme region that holds the isoprenoid tail will display greater activity.

Original languageEnglish (US)
Pages (from-to)764-766
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Issue number3
StatePublished - Feb 1 2013
Externally publishedYes


  • Anti-proliferative
  • Apoptosis
  • Bioassay
  • GGTase II
  • Rab GGTase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'Triazole-based inhibitors of geranylgeranyltransferase II'. Together they form a unique fingerprint.

Cite this